ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 94 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $82 | -96.7% | 620 | -87.3% | 0.00% | – |
| Q2 2023 | $2,499 | -19.1% | 4,901 | 0.0% | 0.00% | – |
| Q1 2023 | $3,088 | -52.4% | 4,901 | -51.0% | 0.00% | -100.0% |
| Q4 2022 | $6,493 | -72.9% | 10,003 | -28.5% | 0.00% | 0.0% |
| Q3 2022 | $24,000 | +41.2% | 13,987 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $17,000 | +88.9% | 13,987 | -7.3% | 0.00% | – |
| Q1 2022 | $9,000 | -10.0% | 15,087 | +183.3% | 0.00% | -100.0% |
| Q3 2021 | $10,000 | -28.6% | 5,326 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $14,000 | -26.3% | 5,326 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $19,000 | 0.0% | 5,326 | -27.5% | 0.00% | 0.0% |
| Q3 2020 | $19,000 | +1800.0% | 7,348 | +1081.4% | 0.00% | – |
| Q4 2018 | $1,000 | -50.0% | 622 | +12.7% | 0.00% | – |
| Q3 2018 | $2,000 | -86.7% | 552 | -76.2% | 0.00% | -100.0% |
| Q1 2017 | $15,000 | -6.2% | 2,315 | -21.9% | 0.00% | -50.0% |
| Q4 2016 | $16,000 | – | 2,966 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 14,013,093 | $9,142,000 | 0.78% |
| MSD Partners, L.P. | 15,151,516 | $9,885,000 | 0.54% |
| MSD Partners, L.P. | 7,575,758 | $4,942,000 | 0.27% |
| CHIRON CAPITAL MANAGEMENT, LLC | 144,960 | $95,000 | 0.06% |
| MAGNOLIA CAPITAL ADVISORS LLC | 185,456 | $121,000 | 0.05% |
| Allred Capital Management, LLC | 128,000 | $83,000 | 0.04% |
| Virtus ETF Advisers LLC | 131,413 | $86,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 232,438 | $152,000 | 0.02% |
| ACT WEALTH MANAGEMENT, LLC | 37,071 | $24,000 | 0.01% |
| Pathway Financial Advisors LLC | 30,000 | $20,000 | 0.01% |